Table 1 Demographic and preoperative characteristics
SAVR (N = 341) | TAVR (N = 238) | P-values | |
|---|---|---|---|
Male sex | 201 (59%) | 118 (49%) | 0.02 |
Age, years | 74.5 ± 7.5 | 81.8 ± 7.2 | < 0.001 |
NYHA functional class I/II/III/IV | 57/217/57/10 | 10/129/73/26 | < 0.001 |
Logistic Euroscore, % | 6.9 ± 4.9 | 14.7 ± 9.4 | < 0.001 |
Euroscore II, % | 2.3 ± 2.3 | 4.8 ± 3.6 | < 0.001 |
Supraventricular arrhythmia | 32 (9%) | 89 (37%) | < 0.001 |
Coronary artery disease | 76 (22%) | 85 (36%) | < 0.001 |
Peripheral vascular disease | 24 (7%) | 50 (21%) | < 0.001 |
Chronic obstructive pulmonary disease | 16 (5%) | 54 (23%) | < 0.001 |
Permanent pacemaker | 4 (1%) | 21 (9%) | < 0.001 |
Chronic kidney disease | 18 (5%) | 116 (49%) | < 0.001 |
Liver disease | 1 (0.3%) | 12 (5%) | < 0.001 |
History of cancer | 11 (3%) | 40 (17%) | < 0.001 |
LVEF, % | 61.8 ± 9.1 | 56.3 ± 12.3 | < 0.001 |
Mean transaortic gradient in aortic stenosis, mmHg | 55.2 ± 13.0 | 51.0 ± 19.3 | 0.005 |